help button home button Am J Pathol JNCI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Related articles in Am J Pathol
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baekkevold, E. S.
Right arrow Articles by Girard, J.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baekkevold, E. S.
Right arrow Articles by Girard, J.-P.
(American Journal of Pathology. 2003;163:69-79.)
© 2003 American Society for Investigative Pathology

Molecular Characterization of NF-HEV, a Nuclear Factor Preferentially Expressed in Human High Endothelial Venules

Espen S. Baekkevold*, Myriam Roussigné{dagger}, Takeshi Yamanaka*, Finn-Eirik Johansen*, Frode L. Jahnsen*, François Amalric{dagger}, Per Brandtzaeg*, Monique Erard{ddagger}, Guttorm Haraldsen* and Jean-Philippe Girard{dagger}

From the Laboratory for Immunohistochemistry and Immunopathology (LIIPAT),* Institute and Department of Pathology, University of Oslo, Rikshospitalet, Oslo, Norway; the Laboratoire de Biologie Vasculaire,{dagger} and the Laboratoire des Interactions Acides Nucléiques/Protéines comme Cibles Pharmacologiques,{ddagger} Institut de Pharmacologie et de Biologie Structurale, CNRS-VMR 5089, Toulouse, France

Lymphocyte homing to secondary lymphoid tissue and lesions of chronic inflammation is directed by multi-step interactions between the circulating cells and the specialized endothelium of high endothelial venules (HEVs). In this study, we used the PCR-based method of suppression subtractive hybridization (SSH) to identify novel HEV genes by comparing freshly purified HEV endothelial cells (HEVECs) with nasal polyp-derived microvascular endothelial cells (PMECs). By this approach, we cloned the first nuclear factor preferentially expressed in HEVECs, designated nuclear factor from HEVs (NF-HEV). Virtual Northern and Western blot analyses showed strong expression of NF-HEV in HEVECs, compared to human umbilical vein endothelial cells (HUVECs) and PMECs. In situ hybridization and immunohistochemistry revealed that NF-HEV mRNA and protein are expressed at high levels and rather selectively by HEVECs in human tonsils, Peyers’s patches, and lymph nodes. The NF-HEV protein was found to contain a bipartite nuclear localization signal, and was targeted to the nucleus when ectopically expressed in HUVECs and HeLa cells. Furthermore, endogenous NF-HEV was found in situ to be confined to the nucleus of tonsillar HEVECs. Finally, threading and molecular modeling studies suggested that the amino-terminal part of NF-HEV (aa 1–60) corresponds to a novel homeodomain-like Helix-Turn-Helix (HTH) DNA-binding domain. Similarly to the atypical homeodomain transcription factor Prox-1, which plays a critical role in the induction of the lymphatic endothelium phenotype, NF-HEV may be one of the key nuclear factors that controls the specialized HEV phenotype.



Related articles in Am J Pathol:

This Month in AJP

Am J Pathol 2003 163: 1-2. [Full Text]  



This article has been cited by other articles:


Home page
Int ImmunolHome page
M. D. Smithgall, M. R. Comeau, B.-R. Park Yoon, D. Kaufman, R. Armitage, and D. E. Smith
IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK Cells
Int. Immunol., June 11, 2008; (2008) dxn060v1.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
L. H. Ho, T. Ohno, K. Oboki, N. Kajiwara, H. Suto, M. Iikura, Y. Okayama, S. Akira, H. Saito, S. J. Galli, et al.
IL-33 induces IL-13 production by mouse mast cells independently of IgE-Fc{epsilon}RI signals
J. Leukoc. Biol., December 1, 2007; 82(6): 1481 - 1490.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Hayakawa, M. Hayakawa, A. Kume, and S.-i. Tominaga
Soluble ST2 Blocks Interleukin-33 Signaling in Allergic Airway Inflammation
J. Biol. Chem., September 7, 2007; 282(36): 26369 - 26380.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. L. Januzzi Jr, W. F. Peacock, A. S. Maisel, C. U. Chae, R. L. Jesse, A. L. Baggish, M. O'Donoghue, R. Sakhuja, A. A. Chen, R. R.J. van Kimmenade, et al.
Measurement of the Interleukin Family Member ST2 in Patients With Acute Dyspnea: Results From the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) Study
J. Am. Coll. Cardiol., August 14, 2007; 50(7): 607 - 613.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. Carriere, L. Roussel, N. Ortega, D.-A. Lacorre, L. Americh, L. Aguilar, G. Bouche, and J.-P. Girard
IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo
PNAS, January 2, 2007; 104(1): 282 - 287.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. A. K. Harvey, S. C. Anderson, and N. SundarRaj
Downstream Effects of ROCK Signaling in Cultured Human Corneal Stromal Cells: Microarray Analysis of Gene Expression
Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2168 - 2176.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D.-A. Lacorre, E. S. Baekkevold, I. Garrido, P. Brandtzaeg, G. Haraldsen, F. Amalric, and J.-P. Girard
Plasticity of endothelial cells: rapid dedifferentiation of freshly isolated high endothelial venule endothelial cells outside the lymphoid tissue microenvironment
Blood, June 1, 2004; 103(11): 4164 - 4172.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
D. Palmeri, F.-R. Zuo, S. D. Rosen, and S. Hemmerich
Differential gene expression profile of human tonsil high endothelial cells: implications for lymphocyte trafficking
J. Leukoc. Biol., May 1, 2004; 75(5): 910 - 927.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Society for Investigative Pathology.